Shandong Xinhua Pharmaceutical Company Limited

Informe acción SEHK:719

Capitalización de mercado: HK$9.7b

Dividendos de Shandong Xinhua Pharmaceutical

Dividendo controles de criterios 0/6

Shandong Xinhua Pharmaceutical es una empresa que paga dividendos con una rentabilidad actual de 0.92%.

Información clave

0.9%

Rentabilidad por dividendo

-0.7%

Rendimiento de la recompra

Rendimiento total para el accionista0.3%
Rendimiento futuro de los dividendosn/a
Crecimiento de los dividendos19.5%
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónHK$0.0546
Ratio de pago38%

Últimas actualizaciones de dividendos

Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year

Jun 28
Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year

Recent updates

Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year

Jun 28
Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year

Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price

Jan 23
Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price

Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt

Mar 07
Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt

Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Nov 18
Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively

Jul 27
These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively

Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18

Jul 04
Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18

Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)

Mar 09
Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)

We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt

Dec 21
We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt

Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?

Apr 06
Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?

What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?

Mar 19
What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?

Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?

Feb 26
Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?

Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 05
Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?

Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years

Jan 18
Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years

Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?

Dec 29
Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?

Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?

Dec 14
Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?

Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Nov 26
Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: 719 no paga un dividendo notable para el mercado Hong Kong, por lo que no es necesario comprobar si los pagos son estables.

Dividendo creciente: 719 no paga un dividendo notable para el mercado Hong Kong, por lo que no es necesario comprobar si los pagos aumentan.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Shandong Xinhua Pharmaceutical vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de 719 con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (719)0.9%
Suelo de mercado 25% (HK)3.2%
Techo de mercado 25% (HK)7.9%
Media de la industria (Pharmaceuticals)3.7%
Analista de previsiones (719) (hasta 3 años)n/a

Dividendo destacado: El dividendo de 719(0.92%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Hong Kong (3.22%).

Alto dividendo: El (0.92%) del dividendo de 719 es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Hong Kong (7.93%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: 719 no paga un dividendo notable para el mercado Hong Kong.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: 719 no paga un dividendo notable para el mercado Hong Kong.


Descubre empresas que pagan buenos dividendos